Market Overview

Tim Sykes Tells Benzinga KaloBios Was A 'Smokescreen', A Supernova That Defied Logic, Have to Be Skeptical In Surge Of Company Not Based On Earnings Or New Product Released

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Analyst Color Biotech Short Ideas Small Cap Analysis Management Exclusives Trading Ideas General

 

Related Articles (KBIO)